US Stock MarketDetailed Quotes

APDN Applied DNA Sciences

Watchlist
  • 0.144
  • -0.001-0.62%
Close Feb 26 16:00 ET
7.95MMarket Cap-0.22P/E (TTM)

About Applied DNA Sciences Company

Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Company Profile

SymbolAPDN
Company NameApplied DNA Sciences
Listing DateNov 17, 2014
Founded1983
CEODr. James A. Hayward, PhD,Sc.D.
MarketNASDAQ
Employees48
Fiscal Year Ends09-30
Address50 Health Sciences Drive
CityStony Brook
ProvinceNew York
CountryUnited States of America
Zip Code11790
Phone1-631-240-8800

Company Executives

  • Name
  • Position
  • Salary
  • Dr. James A. Hayward, PhD,Sc.D.
  • Chairman of the Board and Chief Executive Officer
  • 468.00K
  • Judith Murrah
  • President, Chief Operating Officer, Chief Information Officer and Secretary
  • 542.75K
  • Clay Shorrock
  • Chief Legal Officer and Executive Director of Business Development; President, LRx
  • 501.00K
  • Beth M. Jantzen
  • Chief Financial Officer and Principal Accounting Officer
  • 501.00K
  • Dr. Yacov A. Shamash, PhD
  • Independent Director
  • 162.50K
  • Elizabeth M. Schmalz
  • Independent Director
  • 153.75K
  • Joseph D. Ceccoli
  • Independent Director
  • 155.00K
  • Robert B. Catell
  • Independent Director
  • 152.50K
  • Dr. Sanford R. Simon, PhD
  • Independent Director
  • 151.25K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More